Vaccine Considerations in Patients with Cancer Receiving Systemic Anti-Cancer Therapy (including COVID-19)

Deborah Enting is a Consultant Medical Oncologist at Guy's and St Thomas' NHS Foundation Trust, and an Honorary Senior Lecturer at King's College London. She specialises in the treatment of Urological Cancers and the systemic treatment (chemotherapy, immunotherapy and targeted therapies) for Bladder, Prostate, Kidney and Testicular cancers. Dr Enting undertook her medical training at the University of Groningen in The Netherlands and trained in Medical Oncology at Guy's and St George's Hospitals. She was a research fellow at the Department of Immunobiology at King's College London and in collaboration with colleagues of the Translational Oncology Urology Research (TOUR) group at King’s College London she works on tumour immune surveillance and bladder cancer research. She is the Clinical Lead for Systemic Anti-Cancer Therapies at Guy's Hospital . Together with colleagues within and outside her institution she has led on guidelines for COVID-19 vaccination in cancer patients which have been adopted nationally by the UK Chemotherapy Board.

Raj has specialised in Cancer for over 20 years. Currently she has a 50:50 split role with Barts Health NHS Trust and NHS England.

“My role at the Trust encompasses all the governance aspects involved in the introduction of new cancer related treatments including implementing any National Policy on cancer drugs. 
I am the lead Intrathecal Chemotherapy Trainer and also a Non-Medical Prescriber actively reviewing and prescribing for GI Oncology patients.
I was the Head of Chemotherapy for over ten years, taking the Trust though multiple successful chemotherapy Peer Reviews.
Away from work I run marathons and a proud six star finisher!”

He has worked in oncology pharmacy for over 20 years, and currently runs a number of chemotherapy prescribing clinics across 5 hospitals in the North East of England.  He is a self-proclaimed geek with a keen interest in data and evidence based practice.  He is well known for having an opinion on most things and couldn’t help but get involved in the development of national guidance on vaccines with SACT.

Nisha is the Lead Pharmacist for Cancer Services at Guy’s & St Thomas NHS Foundation Trust & Cancer Commissioning Pharmacist at NHSE/I (London Region). She has worked in oncology for over 20 years, both in the NHS & private sector. Over the years, she has set up and worked in non-medical prescribing chemotherapy clinics for breast cancer patients. In her current role, she oversees the governance and strategic delivery of all systemic anti-cancer therapy services at the Trust and she is a wider member of the pharmacy executive team. More recently, she has been supporting the implementation of the covid-19 vaccination rollout with the pharmacy team at the Trust. Following various discussions, she has worked with her multi-disciplinary panel colleagues to develop a national FAQ document endorsed by the UK Chemotherapy Board to provide consistent clinician advice for SACT patients receiving the covid-19 vaccination. This document has evolved and been updated as more data and guidance has been made available. She has a special interest in Genomics and Advanced Therapy Medicinal Products (ATMPs) and is involved with regional & national working groups to develop and shape this for the future.